Pitt | Swanson Engineering
Bioengineering Professors Davidson, Federspiel, and Ruder receive Swanson School professorship and fellowship appointments

PITTSBURGH (Dec. 5, 2019) … In recognition of outstanding productivity as a faculty member, the University of Pittsburgh Department of Bioengineering appointed two faculty professorships and one faculty fellowship in 2019. Lance Davidson was appointed William Kepler Whiteford Professor of Bioengineering, William Federspiel was appointed John A. Swanson Professor of Bioengineering, and Warren Ruder was appointed William Kepler Whiteford Fellow of Bioengineering.

“In addition to conducting cutting-edge research, each of these individuals is a dedicated teacher and mentor, which is critical for developing the next generation of knowledge creators and professional practitioners,” said Sanjeev G. Shroff, Distinguished Professor and Gerald E. McGinnis Chair of Bioengineering. “I am very proud to have Lance, Bill, and Warren as a part of our bioengineering family.”

Lance Davidson, William Kepler Whiteford Professor of Bioengineering

Lance_DavidsonDavidson’s MechMorpho Lab carries out interdisciplinary research at the interface of physics, engineering, mathematics, and cell biology. They study the mechanics of morphogenesis - the central process of tissue self-assembly that couples physical processes that move cells and tissues with the biological processes that give cells their identity, establish tissue architecture and physiological function. 

Using these tools they have uncovered how mechanics lays out and shapes key germ layers in the embryo that give rise to the central nervous system, how mechanical cues guide cells that form the heart and the cardiovascular system, and how mechanical cues can drive regeneration of skin cells. This work is supported by the United States National Institutes of Health including the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Together with their basic research objectives their long-term engineering objective is to turn the principles of morphogenesis into technology to advance cell and tissue engineering.

 

William Federspiel, John A. Swanson Professor of Bioengineering

Bill_FederspielFederspiel directs the Medical Devices Lab in the McGowan Institute of Regenerative Medicine where researchers develop clinically significant devices for the treatment of pulmonary and cardiovascular ailments by utilizing engineering principles of fluid flow and mass transfer. In particular, Federspiel’s lab have created next-generation artificial lung devices, including portable, wearable devices for adults and children suffering from lung disease. 

His research in artificial lung technology eventually led Federspiel to co-found ALung Technologies, a Pittsburgh-based medical device startup company that develops technology for treating respiratory failure. He serves as head of the scientific advisory board for the company, which is currently gunning clinical trials for their Hemolung® Respiratory Assist System (RAS), a dialysis-like alternative for or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure.

 

Warren C. Ruder, William Kepler Whiteford Fellow and Associate Professor of Bioengineering

Ruder-lowresRuder directs the Synthetic Biology and Biomimetics laboratory where his team focuses on applying synthetic biology constructs, methods, and paradigms to solve a range of biomedical problems. His group aims to both understand the fundamental biology of natural systems as well as re-engineer these systems with synthetic gene networks.

They have expertise in multiple fields including gene network engineering, cell physiology and biomechanics, microfluidics, mechanical engineering and biomaterials. They are currently developing new approaches to embed synthetic gene networks within biomimetic systems that mimic cell, tissue, and organism physiology.

Ruder recently received a prestigious $2.2 million NIH Director’s New Innovator Award to develop magnetically activated gene networks in human cells.

###

 

12/5/2019

Contact: Leah Russell